Literature DB >> 10658037

Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury.

R G Spragg1, R M Smith, K Harris, J Lewis, D Häfner, P Germann.   

Abstract

Synthetic surfactants allow examination of the effects of specific components of natural surfactant. To determine whether surfactant containing apoprotein C, dipalmitoyl-phosphatidylcholine, phosphatidylglycerol, and palmitic acid restores gas-exchanging function in acute lung injury (ALI), we administered such surfactant (in doses of 50 or 100 mg/kg and in volumes from 1 to 6 ml/kg) or phospholipid (PL) alone, by intratracheal instillation, to pigs with ALI induced by massive saline lavage. Animals ventilated with 100% O(2) and receiving 1, 2, 4, or 6 ml/kg of 50 mg/kg recombinant surfactant apoprotein C (rSP-C) surfactant or 2 ml/kg of 50 mg/kg PL (control) had mean arterial PO(2) values, 4 h after treatment, of 230, 332, 130, 142, or 86 Torr, respectively. Animals receiving 1, 2, or 4 ml/kg of 100 mg/kg rSP-C surfactant or 2 ml/kg of 100 mg/kg PL (control) had mean arterial PO(2) values of 197, 214, 148, or 88 Torr, respectively. Surfactant PL distribution was homogeneous. Hyaline membrane formation was reduced in treated animals. Thus, in this model of ALI, rSP-C with PL has the capacity to improve gas exchange and possibly modify lung injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658037     DOI: 10.1152/jappl.2000.88.2.674

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  10 in total

Review 1.  Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?

Authors:  Gautham K Suresh; Roger F Soll
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Optimisation of positive end-expiratory pressure by forced oscillation technique in a lavage model of acute lung injury.

Authors:  Raffaele L Dellacà; Emanuela Zannin; Peter Kostic; Marie Andersson Olerud; Pasquale P Pompilio; Goran Hedenstierna; Antonio Pedotti; Peter Frykholm
Journal:  Intensive Care Med       Date:  2011-04-01       Impact factor: 17.440

3.  Tracheal acid or surfactant instillation raises alveolar surface tension.

Authors:  Tam L Nguyen; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2018-05-17

4.  Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin.

Authors:  William E Lawson; Vasiliy V Polosukhin; Georgios T Stathopoulos; Ornella Zoia; Wei Han; Kirk B Lane; Bo Li; Edwin F Donnelly; George E Holburn; Kenneth G Lewis; Robert D Collins; William M Hull; Stephan W Glasser; Jeffrey A Whitsett; Timothy S Blackwell
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

5.  Synthetic surfactant based on analogues of SP-B and SP-C is superior to single-peptide surfactants in ventilated premature rabbits.

Authors:  Andreas Almlén; Frans J Walther; Alan J Waring; Bengt Robertson; Jan Johansson; Tore Curstedt
Journal:  Neonatology       Date:  2010-01-21       Impact factor: 4.035

6.  Altered stability of pulmonary surfactant in SP-C-deficient mice.

Authors:  S W Glasser; M S Burhans; T R Korfhagen; C L Na; P D Sly; G F Ross; M Ikegami; J A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

Review 7.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

8.  Surfactant protein C dampens inflammation by decreasing JAK/STAT activation during lung repair.

Authors:  Huiyan Jin; Andrzej K Ciechanowicz; Alanna R Kaplan; Lin Wang; Ping-Xia Zhang; Yi-Chien Lu; Rachel E Tobin; Brooke A Tobin; Lauren Cohn; Caroline J Zeiss; Patty J Lee; Emanuela M Bruscia; Diane S Krause
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 6.011

Review 9.  Positive end-expiratory pressure in acute respiratory distress syndrome: should the 'open lung strategy' be replaced by a 'protective lung strategy'?

Authors:  Jean-Jacques Rouby; Fabio Ferrari; Bélaïd Bouhemad; Qin Lu
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  A recipe for a good clinical pulmonary surfactant.

Authors:  Jesús Pérez-Gil
Journal:  Biomed J       Date:  2022-03-08       Impact factor: 7.892

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.